Analyses from a breast cancer patient and cell line databases also demonstrated that OVOL1 expression was inversely correlated with the TGF-β response signature (TBRS)54 or the levels of TGF-β/SMAD target genes (Supplementary Fig. 5c–e). The gene discussed is TGFB1; the disease is breast cancer.